Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
Andreas Engert(University Hospital Cologne), Heinz Haverkamp(University Hospital Cologne), Carsten Kobe(University Hospital Cologne), Jana Marková(University Hospital Kralovske Vinohrady), Christoph Renner(Swiss Group For Clinical Cancer Research), Antony D. Ho(Heidelberg University), Josée M. Zijlstra, Zdeněk Král(Masaryk University), Michael Fuchs(University Hospital Cologne), Michael Hallek(University Hospital Cologne), Lothar Kanz(University of Tübingen), Hartmut Döhner(Universität Ulm), Bernd Dörken(Charité - Universitätsmedizin Berlin), Nicole Engel(Ludwig-Maximilians-Universität München), Max S. Topp(University of Würzburg), Susanne Klutmann(University Medical Center Hamburg-Eppendorf), Holger Amthauer(Charité - Universitätsmedizin Berlin), Andreas Bockisch(University of Duisburg-Essen), Regine Kluge(Leipzig University), Clemens Kratochwil(Heidelberg University), Otmar Schober(University of Münster), Richard Greil(Paracelsus Medical University), Reinhard Andreesen(University Hospital Regensburg), Michael Kneba(University of Lübeck), Michael Pfreundschuh(Saarland University), Harald Stein(Pathodiagnostik Berlin), Hans Theodor Eich(University Hospital Cologne), Rolf‐Peter Müller(University Hospital Cologne), Markus Dietlein(University Hospital Cologne), Peter Borchmann(University Hospital Cologne), Volker Diehl(University Hospital Cologne)
Cited by 632
Abstract
Related Papers
No related papers found
Powered by citation graph analysis